About Yakov Kogan
Form D filings for Sethera Therapeutics in 2024 list Yakov Kogan as executive officer.
Yakov Kogan first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Yakov Kogan in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Yakov Kogan works with at each company, as listed on that company's latest Form D.
Sethera Therapeutics, Inc · Form D, Oct 30, 2024
VB
Vahe Bandarian
Executive officer and director
KE
Karsten Eastman
Chief Executive Officer and director
CT
Cynthia Tsai
Executive officer and director